Stamos Capital Partners L.P. Trims Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Stamos Capital Partners L.P. lowered its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 56.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,240 shares of the pharmaceutical company’s stock after selling 1,630 shares […]

Related Keywords

Canada ,Ourania Tatsis ,Brucei Sachs ,Vertex Pharmaceuticals Profile ,News Ratings For Vertex Pharmaceuticals Daily ,Arthurm Cohen Associates ,Vertex Pharmaceuticals ,Vertex Pharmaceuticals Stock Performance ,Quarter For Vertex Pharmaceuticals ,Securities Exchange Commission ,Royal Bank ,Nasdaq ,Canaccord Genuity Group ,Exchange Commission ,Venturi Wealth Management ,Hohimer Wealth Management ,Nicholas Hoffman Company ,Vertex Pharmaceuticals Incorporated ,Johnson Financial Group Inc ,Free Report ,Wealth Management ,Financial Group ,Pharmaceuticals Incorporated ,Get Free Report ,Director Bruce ,Genuity Group ,Vertex Pharmaceuticals Daily ,